Objectives: The aim of this study was to investigate ventilation in mild to moderate asthmatic patients and age-matched controls using hyperpolarized (HP) 129 Xenon magnetic resonance imaging (MRI) and correlate findings with pulmonary function tests (PFTs). Materials and Methods: This single-center, Health Insurance Portability and Accountability Act-compliant prospective study was approved by our institutional review board. Thirty subjects (10 young asthmatic patients, 26 ± 6 years; 3 males, 7 females; 10 older asthmatic patients, 64 ± 6 years; 3 males, 7 females; 10 healthy controls) were enrolled. After repeated PFTs 1 week apart, the subjects underwent 2 MRI scans within 10 minutes, inhaling 1-L volumes containing 0.5 to 1 L of 129 Xe. 129 Xe ventilation signal was quantified by linear binning, from which the ventilation defect percentage (VDP) was derived. Differences in VDP among subgroups and variability with age were evaluated using 1-tailed t tests. Correlation of VDP with PFTs was tested using Pearson correlation coefficient. Reproducibility of VDP was assessed using Bland-Altman plots, linear regression (R 2 ), intraclass correlation coefficient, and concordance correlation coefficient. Results: Ventilation defect percentage was significantly higher in young asthmatic patients versus young healthy subjects (8.4% ± 3.2% vs 5.6% ± 1.7%, P = 0.031), but not in older asthmatic patients versus age-matched controls (16.8% ± 10.3% vs 11.6% ± 6.6%, P = 0.13). Ventilation defect percentage was found to increase significantly with age (healthy, P = 0.05; asthmatic patients, P = 0.033). Ventilation defect percentage was highly reproducible (R 2 = 0.976; intraclass correlation coefficient, 0.977; concordance correlation coefficient, 0.976) and significantly correlated with FEV 1% (r = −0.42, P = 0.025), FEF 25%-75% (r = −0.45, P = 0.019), FEV1/FVC (r = −0.71, P < 0.0001), FeNO (r = 0.69, P < 0.0001), and RV/TLC (r = 0.51, P = 0.0067). Bland-Altman analysis showed a bias for VDP of −0.88 ± 1.52 (FEV1%, −0.33 ± 7.18).
A sthma has a prevalence of 6% to 8% in the American population that peaks in early childhood, declines in late adolescence, and rises again in the late adulthood before decreasing among the elderly. 1, 2 While the diagnosis and clinical monitoring of asthma mainly use forced expiratory volume in 1 second (FEV1%), these pulmonary function tests (PFTs) do not completely characterize airway physiology. Even in subjects with normal FEV1%, nitrogen washout shows that significant ventilation heterogeneity can be present. 3 Similarly, computed tomography (CT) can reveal heterogeneous regional air-trapping and airway thickening in asthmatic patients 4 with normal PFT results. The most striking shortcoming of PFTs is their broad variation with age, standing height, sex, and ethnic group. 5, 6 These observations support the need for more precise and reliable measurements that do not require such scaling. In addition to being highly variable, PFTs also cannot depict regional ventilation or its heterogeneity. Ventilation defects could represent preclinical stages of disease, offering the opportunity of better monitoring disease progress or treatment efficiency. Another possible application could include early detection of disease-related ventilation defects to further avoid exacerbations. 7 To this end, xenon-enhanced dual-energy CT has been able to depict regional ventilation but confers a considerable radiation dose, which particularly limits the use in healthy subjects and young individuals. 8 Therefore, MRI techniques are emerging that use short echo time sequences in conjunction with oxygen shortening lung tissue T1 to provide a surrogate of regional ventilation. 9 Although the oxygen enhancement signal depends on more than regional ventilation, it has been shown to significantly correlate with PFT measurements. However, oxygen-enhanced MRI is hampered by relatively small signal, long acquisition times, and the need for subtraction that can make it prone to misregistration artifacts. 10 Even more advantageous are nonproton MR methods that directly image nonendogenous inhaled agents, such as perfluorinated gases, without background signal. 11 However, the most thoroughly investigated and mature nonproton method over the last 2 decades has been hyperpolarized (HP) 3 He MRI. [12] [13] [14] [15] This technique also readily depicts ventilation heterogeneity and defects and has been used to visualize the effects of both bronchoprovocation and bronchodilation. 16 The observed ventilation defects on HP 3 He MRI significantly correlated with areas of air-trapping, resulting from airway remodeling encountered on CT. 17 3 He MRI has shown that older asthmatic patients exhibit significantly more ventilation defects than younger ones.
11 Unfortunately, 3 He gas is in short supply and faces sharply rising costs, which has increased interest in readily available HP 129 Xe. This gas has already been shown to detect more ventilation defects in asthmatic patients than 3 He. 18 However, there are no studies further investigating obstructive patterns in asthma with 129 Xe MRI or correlating this technique with PFTs. This gap must be addressed in order for 129 Xe MRI to expand into clinical practice.
The purpose of our study was to investigate if 129 Xe MRI would (a) correlate significantly with established lung function metrics; (b) accurately depict differences in ventilation defect percentage (VDP) between asthmatic patients and healthy controls; and (c) be reproducible at baseline.
MATERIALS AND METHODS
This prospective, single-center Health Insurance Portability and Accountability Act-compliant study was approved by the institutional review board and registered at clinicaltrials.gov. All subjects gave informed, written consent before study enrollment.
Patients
Between January 2012 and March 2014, 30 subjects were prospectively recruited for this study (20 asthmatic patients, 10 agematched healthy controls). Both study populations were matched for sex, asthma medication use, and percent predicted forced expiratory volume (FEV1%). Asthma was confirmed with a methacholine challenge test according to American Thoracic Society guidelines. 6 The population was further stratified by age to young (18-35 years; n = 9) and older (55-75 years; n = 10) asthmatic patients, and included 5 age-matched healthy subjects for each age group.
The following exclusion criteria were applied: (1) smoking history of more than 5 pack-years or smoked for the past 2 years; (2) prebronchodilator FEV1% < 60%; (3) diffusing capacity of the lung for carbon monoxide (DLCO) < 80% predicted; (4) asthma exacerbation requiring oral corticosteroids or respiratory tract infection in the past 6 weeks; (5) had been hospitalized for respiratory disease in the past 3 months; and (6) were asthmatic and using more than shortacting β-agonist and/or inhaled corticosteroids (dose equivalent of ≤250 mg fluticasone). General contraindications for MRI also resulted in exclusion from the study.
All individuals participated in 3 separate visits on different days at the same time of the day within ±2 hours ( Fig. 1) . On the first visit, clinical characteristics were recorded and a physical examination was performed. During this session, DLCO and fractional exhaled nitric oxide (FeNO) were measured, and the Asthma Quality of Life Questionnaire (AQLQ), as well as the Asthma Control Questionnaire (ACQ), was administered. 19 At the second visit (1 week ± 3 days later), subjects returned to the clinic and repeated spirometry, DLCO, AQLQ, FeNO, and sequential sputum induction to more accurately measure these parameters (learning/training effect). At the third and final visit,
129
Xe ventilation MRI was performed.
Pulmonary Function Testing
Spirometry, plethysmography, and DLCO were performed using the Vmax Autobox and SensorMedics (CareFusion, San Diego, CA). Spirometry was used to measure FEV1, FEF 25%-75% , and FVC, whereas plethysmography was used to assess lung volumes (total lung capacity [TLC], residual volume [RV] ). Ratios such as FEV1/FVC and RV/TLC were calculated from raw data, but all values are reported as percentage of the predicted values for subjects of comparable characteristics. Fractional exhaled nitric oxide, indicating airway inflammation, was measured using the Niox Mino (Aerocrine Inc USA, Morrisville, NC). Asthmatic patients were classified according to the guidelines of the US National Asthma Education and Prevention Program.
Magnetic Resonance Imaging
Hyperpolarized 129 Xe MRI scans were performed on a 1.5 T GE Healthcare EXCITE 15M4 MR system. Isotopically enriched 129 Xe gas (83% 129 Xe) was polarized to 6% to 10% by spin-exchange optical pumping. 20 Subjects underwent 2 fast gradient echo 129 Xe ventilation MRI scans in the supine position, 10 minutes apart, using 1 L of total gas volume, composed of 0.5 to 1 L of HP 129 Xe, mixed with N 2 buffer gas as described previously. 21 In all cases, the subject received a total volume of gas of 1 L. The xenon volume was determined by the duration of cryogenic accumulation and total gas flow rate. As 129 Xe polarization levels became higher, smaller predetermined 129 Xe volumes could be used. In case this volume was less than 1 L, helium buffer gas was added to make 1 L.
From each
129
Xe MRI scan, VDP was calculated using the linear-binning approach. 22 Subjects were fitted with a flexible chest coil (Clinical MR Solutions, Brookfield, WI) that was tuned to a 17.66-MHz
Xe frequency and proton-blocked to permit anatomical scans to be acquired using the 1 H body coil. After being positioned on the scanner bed, subjects first inhaled a test dose of room air to learn the breathing maneuver. 1 H images were acquired in a separate breath hold before the 129 Xe scan. For the 1 H scans, subjects inhaled 1 L of air from the gas bag to achieve a similar level of lung inflation. Individuals were coached to inhale 129 Xe from functional residual capacity. A first bag of gas mixture was used to calibrate the scanner transmit/receive settings Xe, mixed with N 2 buffer gas. The 2 xenon doses were administered to the patient in the supine position. Specific sequence parameters are summarized in Table 1 .
Image Analysis
Images were quantified to determine their VDP using a corrected, semiautomated linear-binning approach, first described by He et al. 22 The analysis of the Xe signal was confined to a mask generated by segmenting the proton images to delineate the thoracic cavity. Before segmentation, these images had been registered to the HP Xe signal intensities within the lungs were color-coded on the ventilation maps: red indicates defect; yellow, low intensity; green, medium intensity; and blue, high signal intensity. Before statistical analysis, the HP 129 Xe ventilation images and the corresponding color-coded maps were reviewed in consensus by 2 readers (blinded to the review process, with 6 and 10 years of experience in chest imaging) to verify that image quality was suitable. Image quality was determined to be inadequate for further analysis if the images exhibited extensive coil shading or insufficient signal to noise to undergo binning analysis.
Statistical Analysis
Statistical analysis was performed using JMP 12 (SAS Institute Inc, Cary, NC) and MedCalc 16.1 (MedCalc Software, Ostend, Belgium). Ventilation defect percentage and its change with age were compared between healthy subjects and asthmatic patients using 1-tailed tests; these were justified based on prior knowledge that VDP increases with asthma and age. 23 Correlation between VDP and PFTs was evaluated using the Pearson correlation coefficient (r). Reproducibility of VDP over the 2 consecutive scans was assessed using linear regression, intraclass correlation coefficient, concordance correlation FIGURE 2. Example of false ventilation defects caused by artifacts. A, In this healthy young volunteer, VDP was 7.28% at baseline and 8.33% at second scan. Ventilation defect percentage clusters less than 0.2 (red) were slightly visible at baseline and become more severe at rescan. These defects could be attributed to rib cage impressions (white arrows) representing artifacts. These artifacts were identified during the review and were resolved by manual resegmentation. B, Young asthmatic subject with FEV1% = 80%, which had to be excluded because of extensive coil shading, which caused the binning algorithm (C) to overestimate VDP at 22.4%. Figure 2 can be viewed online in color at www.investigativeradiology.com.
coefficient, 21 as well as by Bland-Altman analysis. Results were considered statistically significant with P < 0.05.
RESULTS

Patients
A total of 30 subjects were enrolled and completed the entire study protocol, with no serious adverse events reported during the imaging sessions. Mild adverse effects related to xenon inhalation (tingling, euphoria, dizziness) resolved within 3 minutes after exhalation. No further adverse effects could be observed. One patient was excluded because the MRI scans were corrupted by shading artifacts, determined to be caused by a malfunctioning coil (Fig. 2) . This artifact could not be corrected by retrospective bias field correction due to insufficient signal. This resulted in a final sample size of 29 subjects, of which 19 were mild to moderate asthmatic patients. Pulmonary function test and VDP results are displayed in Table 2 .
HP 129
Xe MRI Ventilation Defect Analysis
Among all the patients included in the final study cohort, healthy young volunteers yielded the most uniform 129 Xe distribution (VDP, 5.6% ± 1.7%; Fig. 3 ). By comparison, young asthmatic patients exhibited significantly more ventilation defects (VDP, 8.4% ± 3.2%; P = 0.031; Fig. 4 ). Similarly, older asthmatic patients also showed more Xe distribution during the breath hold is largely homogeneous. In the corresponding maps, faint red clusters are primarily attributable to slight misregistration, yielding VDP = 3.83%. Right, 129 Xe MRI of an older healthy volunteer with FEV1% = 102%. Compared with the young normal, this subject exhibits modest defects in the lung periphery, leading to VDP = 14.4%. Figure 3 can be viewed online in color at www.investigativeradiology.com.
defects than older healthy subjects (16.8% ± 10.3% vs 11.6% ± 6.6%; Figs. 3, 4) . However, this difference was not significant (P = 0.13). Older subjects generally exhibit higher VDP (Fig. 2) , and this increase with age was found to be statistically significant (healthy subjects, P = 0.05; asthmatic patients, P = 0.02) ( Table 3) .
Comparison of VDP and PFTs
Correlation results are reported in Table 4 . Ventilation defect percentage showed a moderate correlation with FEV1% (r = −0.42, P = 0.025), FEF 25%-75% (r = −0.45, P = 0.019), and RV/TLC (r = 0.51, P = 0.0067), and a strong correlation with FEV1/FVC (r = −0.70, P < 0.0001; Fig. 5 ). In addition to PFTs, VDP also correlated strongly with the FeNO (r = 0.69, P < 0.0001). Ventilation defect percentage did not correlate significantly with FVC, DLCO, ACQ, and the AQLQ questionnaires.
Repeatability of HP 129
Xe VDP and PFTs
The repeatability of VDP proved to be excellent with an intraclass correlation coefficient of 0.977 and concordance correlation coefficient of 0.976 between the 2 MRI scans. Figure 6 , A and B, additionally show the results of linear regression and Bland-Altman analysis for VDP. Linear regression yielded an excellent least squares fit for VDP with R 2 = 0.976 (P < 0.0001). Bland-Altman analysis depicted a small bias (±SD) in VDP of −0.88 ± 1.52, which is largely driven by 2 subjects who had a difference of~4% between the 2 scans. In contrast, the variability in FEV1% at 1 week was ±183 mL (7.18%) across the subject population, which is well illustrated by the Bland-Altman plot for FEV1% (Fig. 6D) .
DISCUSSION
Our study results show that the VDP derived from HP 129 Xe MRI is able to detect regional obstruction and significantly correlates with PFTs.
Ventilation defect percentage was moderately to strongly correlated with FEV1%, FEF 25%-75% , FEV1/FVC, and RV/TLC. FEV1% is the predominant metric used for quantitative assessment of airflow limitation in asthma. 24, 25 Of note, VDP correlated significantly with FEV1%, FEF 25%-75% , FEV1/FVC, and RV/TLC. However, numerous subjects with normal FEV1% exhibit pronounced ventilation defects, and yet others with abnormal FEV1% exhibit almost normal lung ventilation on MR. This speaks to the different ways these 2 techniques are sensitive to obstruction. In order for HP 129 Xe to be detectable in a given voxel, the gas must travel largely unobstructed through all 23 generations of airways. This makes HP 129 Xe MRI inherently sensitive to the entire bronchial tree, whereas the measurement of FEV1% is known to be dominated by contributions from the larger airways. 26 
HP 129
Xe VDP further correlated with FEF 25%-75% (r = −0.45, P = 0.019), which is thought to be a more sensitive indicator of small airways obstruction. This parameter reflects the most effortindependent segment of the spirometric curve, dominated by flow in the small airways. It is here that diseases of chronic airflow obstruction are thought to start, and thus, the correlation of FEF 25%-75% with HP 129 Xe VDP bolsters the notion that VDP is indeed sensitive to small airways obstruction. Because FEF 25%-75% is known to be less reproducible than The acquired parameters were tested for significant differences among the healthy and asthma subjects, and also for change with age. Note: significant differences are displayed in bold font-type.
PFT indicates pulmonary function test; FEV1%, forced expiratory volume in 1 second; FVC%, forced vital capacity; FEF, forced mid-expiratory flow rate; RV/TLC, residual volume/total lung capacity; DLCO, diffusing capacity of the lung for carbon monoxide; FeNO, fractional exhaled nitric oxide; HP, hyperpolarized; MRI, magnetic resonance imaging; VDP, ventilation defect percentage.
FEV1%
, 27 HP 129 Xe MRI may provide a more reliable metric of small airways obstruction. A finding of potential clinical interest was the strong correlation between VDP and FeNO (r = 0.69, P < 0.0001), which reflects inflammatory activity and may thus aid in the distinction between young asthmatic patients and young healthy subjects. The sputum eosinophilic count was another recorded measure of airway inflammation; this measure did not correlate with VDP.
The comparison between HP
129
Xe VDP and PFTs are relatively virgin ground. To the best of our knowledge, there are only 2 comparable publications addressing the correlations of HP 129 Xe VDP and spirometry. In a cohort of COPD subjects, Kirby and coworkers showed a significant correlation between 3 He and HP
Xe MRI VDP, as well as their correlation to FEV1% and FEV1/FVC. In addition, they found that VDP derived from HP 129 Xe MRI was significantly higher than from 3 He. 28 Kirby and colleagues emphasized that the low density of helium likely makes it less sensitive to obstruction than xenon. To date, the sole study of HP 129 Xe MRI in an asthma population was conducted by Svenningsen et al 16 who focused primarily on bronchodilator response and did not report on baseline correlations of HP 129 Xe VDP with PFTs.
One cannot overemphasize the need for reproducible markers of airway obstruction. The high degree of variability of FEV1% is one of the major reasons why respiratory clinical trials require large numbers of patients to record an effect. By comparison, the high repeatability observed with HP 129 Xe MRI has the potential to mitigate the variability impacting PFTs. We evaluated the repeatability of HP 129 Xe MRI by conducting short-term follow-up scans as previously reported with 3 He MRI. 29 In particular, the Bland-Altman analysis yielded only a minimal variation of ±1.52%, whereas the variability of FEV1% was found to be ±7.18%. Although the time between FEV1 measurements was considerably longer than for HP 129 Xe MRI, such variability is consistent with the known short-term variability of FEV1%. 25 
